Epigenetics Market Size To Reach $39.15 Billion By 2030

September 2018 | Report Format: Electronic (PDF)

Epigenetics Market Growth & Trends

The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.10% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.

Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.

key Request a free sample copy or view report summary: Epigenetics Market Report

Epigenetics Market Report Highlights

  • By product, the reagents segment accounted for the largest revenue share of 31.50% in 2022 owing to the existence of a number of technology platforms that facilitate analysis at gene, protein, or cellular levels, which encourages innovation in the global marketplace

  • By application, the oncology segment accounted for the largest revenue share of 69.23% in 2022. The segment is expanding as a result of the increased incidence of cancer and the number of cancer-related fatalities globally

  • By technology, the histone acetylation segment is anticipated to register the fastest CAGR of 15.8% from 2023 to 2030 due to its improved efficacy as a result of the development of innovative methods

  • North America dominated the market with the highest revenue share of 38.18% in 2022 owing to government support and increasing R&D funding by government and private organizations

Epigenetics Market Segmentation

Grand View Research has segmented the global epigenetics market report on the basis of product, application, technology, and region:

Epigenetics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Reagents

  • Kits

    • Chip sequencing kit

    • Whole Genomic Amplification Kit

    • Bisulfite Conversion kit

    • RNA sequencing kit

    • Others

  • Instruments

  • Enzymes

  • Services

Epigenetics Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • DNA Methylation

  • Histone Methylation

  • Histone Acetylation

  • Large noncoding RNA

  • MicroRNA Modification

  • Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Oncology

    • Solid Tumors

    • Liquid Tumors

  • Non-Oncology

    • Inflammatory Diseases

    • Metabolic Diseases

    • Infectious Diseases

    • Cardiovascular Diseases

Epigenetics Regional Outlook(Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players of Epigenetics Market

  • Roche Diagnostics

  • Thermo Fisher Scientific, Inc.

  • Eisai Co. Ltd.

  • Novartis AG

  • Element Biosciences, Inc.

  • Dovetail Genomics LLC.

  • Illumina, Inc.

  • ValiRx Plc.

  • Abcam plc.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.